FRT vs NNVC · rev $1.28B vs $22.2M cap
FRT (FRT) versus NanoViricides Inc (NNVC) — a side-by-side from cached financials, not a winner call.
FRT (FRT) common stock.
NanoViricides Inc (NNVC) is a biotechnology company listed on US.
Latest reported FRT revenue for 2025-12-31 was $1.28B. Net income was $411.1M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. FRT currently screens at market cap $0.
Latest reported NNVC revenue for 2026-03-31 was $0. Net income was -$6.0M. NNVC currently screens at market cap $22.2M.
FRT currently screens at market cap $0. NNVC currently screens at market cap $22.2M.
Not investment advice. Open the FRT and NNVC stock pages for the full models.
Not investment advice.